These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32460001)

  • 1. Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity.
    Nijman SMB
    Trends Cancer; 2020 Jun; 6(6):454-461. PubMed ID: 32460001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
    Biswas A; De S
    Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Plasticity: The Role of mRNA Translation.
    Lee LJ; Papadopoli D; Jewer M; Del Rincon S; Topisirovic I; Lawrence MG; Postovit LM
    Trends Cancer; 2021 Feb; 7(2):134-145. PubMed ID: 33067172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing intra-tumoral heterogeneity and therapy resistance.
    Rybinski B; Yun K
    Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again!
    Wooten DJ; Quaranta V
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):167-175. PubMed ID: 28396217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer.
    Ravindran Menon D; Hammerlindl H; Torrano J; Schaider H; Fujita M
    Theranostics; 2020; 10(14):6261-6277. PubMed ID: 32483452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine.
    Gerlinger M; Swanton C
    Br J Cancer; 2010 Oct; 103(8):1139-43. PubMed ID: 20877357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.
    Easwaran H; Tsai HC; Baylin SB
    Mol Cell; 2014 Jun; 54(5):716-27. PubMed ID: 24905005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
    Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
    J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance.
    Das PK; Pillai S; Rakib MA; Khanam JA; Gopalan V; Lam AKY; Islam F
    Stem Cell Rev Rep; 2020 Apr; 16(2):397-412. PubMed ID: 31965409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary scalpels for dissecting tumor ecosystems.
    Rosenbloom DIS; Camara PG; Chu T; Rabadan R
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):69-83. PubMed ID: 27923679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular Plasticity in Cancer.
    Yuan S; Norgard RJ; Stanger BZ
    Cancer Discov; 2019 Jul; 9(7):837-851. PubMed ID: 30992279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumor heterogeneity: evolution through space and time.
    Swanton C
    Cancer Res; 2012 Oct; 72(19):4875-82. PubMed ID: 23002210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance, epigenetics, and tumor cell heterogeneity.
    Hoey T
    Sci Transl Med; 2010 Apr; 2(28):28ps19. PubMed ID: 20410528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics as a mediator of plasticity in cancer.
    Feinberg AP; Levchenko A
    Science; 2023 Feb; 379(6632):eaaw3835. PubMed ID: 36758093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer heterogeneity: converting a limitation into a source of biologic information.
    Rübben A; Araujo A
    J Transl Med; 2017 Sep; 15(1):190. PubMed ID: 28886708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
    Wilting RH; Dannenberg JH
    Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor progression: chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution.
    Huang S
    Prog Biophys Mol Biol; 2012 Sep; 110(1):69-86. PubMed ID: 22579660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression.
    Lüönd F; Tiede S; Christofori G
    Br J Cancer; 2021 Jul; 125(2):164-175. PubMed ID: 33824479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.